Tag: clinical trials
Telix Pharmaceuticals expands US manufacturing ops with IsoTherapeutics acquisition
Telix Pharmaceuticals Limited announced its agreement to acquire IsoTherapeutics Group, a specialty radiopharmaceutical development and bioconjugation firm headquartered in Angleton, Texas.
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.Â
Victoria invests $10m to kickstart eye clinical trials centre
Minister for Industry and Innovation Ben Carroll announced that Breakthrough Victoria will invest $10 million in a new eye clinical trials centre at the Royal Victorian Eye and Ear Hospital to boost the number of clinical trials for world-first treatments for eye disease.
IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...
Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...
Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate
The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...
CSL partners with University of Queensland and CEPI to advance development and manufacture of...
Media Release
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL (ASX:CSL) and The University of Queensland (UQ) today announced that they have entered into a...
Large scale manufacturing of synthetic organs could address problem of long transplant lists
Harvard Bioscience is ramping up its production of synthetic tracheas to supply clinical trials with the highly experimental technology which is slowly moving from...